University of Texas Rio Grande Valley

ScholarWorks @ UTRGV
Biology Faculty Publications and Presentations

College of Sciences

3-2021

Mitochondrial OPA1 cleavage is reversibly activated by
differentiation of H9c2 cardiomyoblasts
Iraselia Garcia
The University of Texas Rio Grande Valley

Fredy Calderon
The University of Texas Rio Grande Valley

Patrick De la Torre
The University of Texas Rio Grande Valley

Shaynah St. Vallier
The University of Texas Rio Grande Valley

Cristobal Rodriguez
The University of Texas Rio Grande Valley

See next page for additional authors

Follow this and additional works at: https://scholarworks.utrgv.edu/bio_fac
Part of the Biology Commons

Recommended Citation
Garcia, I., Calderon, F., la Torre, P. D., Vallier, S. St., Rodriguez, C., Agarwala, D., Keniry, M., Innis-Whitehouse,
W., & Gilkerson, R. (2021). Mitochondrial OPA1 cleavage is reversibly activated by differentiation of H9c2
cardiomyoblasts. Mitochondrion, 57, 88–96. https://doi.org/10.1016/j.mito.2020.12.007

This Article is brought to you for free and open access by the College of Sciences at ScholarWorks @ UTRGV. It has
been accepted for inclusion in Biology Faculty Publications and Presentations by an authorized administrator of
ScholarWorks @ UTRGV. For more information, please contact justin.white@utrgv.edu, william.flores01@utrgv.edu.

Authors
Iraselia Garcia, Fredy Calderon, Patrick De la Torre, Shaynah St. Vallier, Cristobal Rodriguez, Divya
Agarwala, Megan Keniry, Wendy Innis-Whitehouse, and Robert Gilkerson

This article is available at ScholarWorks @ UTRGV: https://scholarworks.utrgv.edu/bio_fac/92

Mitochondrion 57 (2021) 88–96

Contents lists available at ScienceDirect

Mitochondrion
journal homepage: www.elsevier.com/locate/mito

Mitochondrial OPA1 cleavage is reversibly activated by differentiation of
H9c2 cardiomyoblasts
Iraselia Garcia a, b, Fredy Calderon a, Patrick De la Torre a, Shaynah St. Vallier a,
Cristobal Rodriguez a, Divya Agarwala a, Megan Keniry a, Wendy Innis-Whitehouse c,
Robert Gilkerson a, d, *
a

Department of Biology, The University of Texas Rio Grande Valley, Edinburg, TX, USA
Department of Biology, South Texas College, McAllen, TX, USA
Biomedical Sciences, The University of Texas Rio Grande Valley, Edinburg, TX, USA
d
Clinical Laboratory Sciences, The University of Texas Rio Grande Valley, Edinburg, TX, USA
b
c

A R T I C L E I N F O

A B S T R A C T

Keywords:
Mitochondria
OPA1
OMA1
Differentiation
Cardiac
Cultured cell

Optic atrophy-1 (OPA1) is a dynamin-like GTPase localized to the mitochondrial inner membrane, playing key
roles in inner membrane fusion and cristae maintenance. OPA1 is regulated by the mitochondrial transmembrane
potential (Δψm): when Δψm is intact, long OPA1 isoforms (L-OPA1) carry out inner membrane fusion. Upon loss
of Δψm, L-OPA1 isoforms are proteolytically cleaved to short (S-OPA1) isoforms by the stress-inducible OMA1
metalloprotease, causing collapse of the mitochondrial network and promoting apoptosis. Here, we show that LOPA1 isoforms of H9c2 cardiomyoblasts are retained under loss of Δψm, despite the presence of OMA1. However,
when H9c2s are differentiated to a more cardiac-like phenotype via treatment with retinoic acid (RA) in low
serum media, loss of Δ ψm induces robust, and reversible, cleavage of L-OPA1 and subsequent OMA1 degra
dation. These findings indicate that a potent developmental switch regulates Δ ψm-sensitive OPA1 cleavage,
suggesting novel developmental and regulatory mechanisms for OPA1 homeostasis.

1. Introduction
Mammalian OPA1 is localized to the mitochondrial inner membrane,
playing a key role in coordinating mitochondrial structure, bio
energetics, and stress response. Expressed as 8 different mRNAs due to
variable splicing (Delettre et al., 2001; Olichon et al., 2007; Akepati
et al., 2008), mitochondrial OPA1 is present as five distinct protein
isoforms. Two long (L-OPA1) isoforms can be cleaved at either the S1 or
S2 sites to generate three short S-OPA1 isoforms (Griparic et al., 2007).
L-OPA1 mediates inner membrane fusion (Song et al., 2007; Baricault
et al., 2007), either by binding cardiolipin or through homodimeric
association (Ban et al., 2017), while S-OPA1 isoforms are released into
the intermembrane space and are fusion-inactive (Song et al., 2007;
Ishihara et al., 2006). Loss of L-OPA1 and accumulation of S-OPA1
promotes apoptosis (Head et al., 2009; Jiang et al., 2014) and autophagy

(Chen et al., 2016). Consistent with this, increased expression of OPA1
confers protection against apoptotic stimuli (Civiletto et al., 2015;
Merkwirth et al., 2008), while loss of OPA1 expression sensitizes cells to
apoptosis (Frezza et al., 2006); demonstrating the importance of OPA1
to mitochondrial structure/function homeostasis and cellular stress
response.
L-OPA1 isoforms are cooperatively cleaved by the inner membrane
proteases YME1L and OMA1 (Anand et al., 2014). YME1L constitutively
cleaves L-OPA1 for steady-state levels of S-OPA1 (Griparic et al., 2007;
Guillery et al., 2008), while OMA1 cleaves L-OPA1 in response to loss of
transmembrane potential across the inner membrane (Δψm) (Head et al.,
2009; Ehses et al., 2009) as an inducible protease activated by a range of
stress stimuli (Rainbolt et al., 2016). Following import to the mito
chondria, OMA1 is cleaved to a mature form by AFG3L2 (Consolato
et al., 2018). In response to loss of Δψm, OMA1 cleaves L-OPA1 and then

Abbreviations: AFG3L2, AFG3-like protein 2; CAP, chloramphenicol; CCCP, carbonyl cyanide m-chlorophenyl hydrazine; Δ ψm, mitochondrial transmembrane
potential; DRP1, dynamin-related protein 1; OMA1, overlapping activity with m-AAA protease 1; OPA1, optic atrophy 1; PVDF, polyvinylidene fluoride; RA, retinoic
acid; TAE, Tris-acetate EDTA; TBST, Tris-buffered saline plus Tween; TMRE, tetramethyl rhodamine ester.
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undergoes self-cleavage (Zhang et al., 2014) in a YME1L-dependent
manner (Rainbolt et al., 2016). The activation of OMA1 in response to
loss of Δψm requires the matrix-oriented N-terminal domain of OMA1
(Baker et al., 2014); however, the underlying mechanism of stresssensitive OMA1 activation remains unclear.
Consistent with OPA1′ s roles in mitochondrial homeostasis and
apoptotic induction, recent work suggests that OPA1 has broad impor
tance in cellular development and differentiation. Mitochondrial fusion
is mechanistically involved in cell cycle progression (Mitra et al., 2009),
with OPA1 specifically required for maintenance of germline stem cells
(Sênos Demarco et al., 2019) and developmental angiogenesis (Herk
enne et al., 2020). OPA1 expression is upregulated during cardiac dif
ferentiation of stem cells (Magalhães-Novais et al., 2020), while
disruption of OPA1 prevents cardiomyocyte differentiation (Kasahara
et al., 2013), suggesting a key role for OPA1 in cardiac development.
Despite the emerging importance of OPA1, however, developmental
regulation of Δψm-sensitive OPA1 cleavage has not been reported.
Previously, we found that OMA1 controls a sharply-defined threshold of
Δψm required for OPA1-mediated mitochondrial fusion in 143B osteo
sarcoma cells (Jones et al., 2017). In exploring whether a similar
threshold might exist in H9c2 cardiomyoblasts, we find that L-OPA1 is
retained despite loss of Δψm, but that Δψm-sensitive L-OPA1 cleavage is
fully and reversibly activated by retinoic acid (RA)-mediated differen
tiation. These findings indicate that a novel developmental switch
potently activates Δψm-sensitive OPA1 cleavage, raising exciting new
questions regarding the underlying mechanisms and developmental
roles of OPA1-mediated mitochondrial stress response.

2. Methods
2.1. Cell culture
H9c2 cardiomyoblasts from R. norvegicus (ATCC CRL-1446), 143B
osteosarcomas, and OMA1+/+ and − /− mouse embryonic fibroblasts,
were grown in Gibco Dulbecco’s Modified Eagle’s Medium (with high
glucose, L-glutamine, phenol red, and sodium pyruvate) supplemented
with 10% fetal bovine serum and Gibco antibiotic/antimycotic in 5%
CO2 at 37 ◦ C. For carbonyl cyanide chlorophenyl hydrazone (CCCP)
treatments, CCCP (Sigma) was added to media from 1 mM stock in
DMSO for indicated times and concentrations. Differentiation of H9c2s
was performed using the method of Branco et al. (2015): 350,000 cells
were plated per 10 cm dish in DMEM + 10% FBS. The following day,
differentiation was initiated by replacing the media with DMEM + 1%
FBS + 1 μM RA (Sigma, from 1 mM stock in DMSO). RA-mediated dif
ferentiation proceeded for 5 days, with media changed every day. For
undifferentiated controls, 50,000 cells were plated per 10 cm dish in
DMEM + 10% FBS and grown alongside for 5 days. For galactose ex
periments, cells were grown in DMEM lacking glucose (Gibco
11966025) supplemented with sodium pyruvate and galactose with
10% FBS for three passages prior to lysate preparation.
2.2. Confocal imaging and analysis
For immunofluorescence microscopy (Fig. 1), cultured cells grown
on 22 × 22 mm glass coverslips in 6-well culture dishes were washed
briefly with PBS and fixed with 4% paraformaldehyde (Electron Mi
croscopy Sciences, Hatfield, PA) and permeabilized with 0.1% TX-100 in
Fig. 1. Loss of Δψm causes fragmenta
tion of the mitochondrial network. A.
Confocal microscopy of H9c2 and 143B
cells without or with CCCP treatment
(10 μM, 1 h) immunolabeled for mito
chondrial TOM 20 (green). Nuclei
stained with DAPI (cyan). n = 3 experi
ments (biological replicates). Size bar =
2 μm. B. ImageJ quantification of mito
chondrial circularity calculated from
confocal images (detail) in A. n = 25
images for each, ± standard error. ***
denotes p < 0.001. C. TMRE flow
cytometry of H9c2 and 143B cells
without or with CCCP, 10 μM, 1 h. n ≥ 3
experiments, ± standard error. ** de
notes p < 0.01.
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PBS for 10 min. Samples were blocked with 10% normal goat serum and
immunolabeled with anti-TOM20 rabbit polyclonal antibody (FL-145,
Santa Cruz Biotechnology, Santa Cruz, CA) at 1:100 dilution in PBS
(note: antibody FL-145 is no longer available; the replacement, FL-10,
reacts with human but not rat). Coverslips were washed briefly with
PBS and incubated with goat anti-mouse AlexaFluor488 (Invitrogen
Molecular Probes, Carlsbad, CA), followed by staining with dia
minophenylindole (DAPI) to visualize cell nuclei, washed with PBS, and
mounted in 50% glycerol in PBS. For imaging of differentiated H9c2 cell
morphology (Fig. 3A), cells were fixed in 4% paraformaldehyde, washed
briefly, and incubated with AlexaFluor488 phalloidin (Invitrogen Mo
lecular Probes) and DAPI, as above. Coverslips were visualized on an
Olympus Fluoview FV10i confocal microscope (Olympus, Waltham,
MA) using a 60x objective (UPLSA60x W, aperture 1.0, 3.0 optical
zoom). To quantify mitochondrial circularity, blinded ImageJ analysis
was used as previously (Dagda et al., 2009; Garcia et al., 2018): mi
croscopy samples were prepared and imaged with generic labeling,
generating a sample size of n = 25 high resolution images for analysis.
For each high resolution image (examples: Fig. 1A, detail images),
ImageJ calculated the average circularity of the mitochondrial profiles
in that image using the ImageJ Mitochondrial Morphology macro (htt
p://imagejdocu.tudor.lu/doku.php?id=plugin:morphology:mitocho
ndrial_morphology_macro_plug-in:start). To monitor mitochondrial
morphology (Fig. 3F), RA-treated H9c2s were labeled with 40 nM
MitoTracker Red CMXRos (Invitrogen Molecular Probes, Eugene, Ore
gon) for 20 min. followed by incubation in media lacking or containing
10 μM CCCP for 1 h, fixation in 4% paraformaldehyde for 30 min., and
mounting/visualization.

mL of PBS. Cells were analyzed on a BD FACSCelesta or LSR Fortessa (BD
Biosciences). All flow cytometry graphs indicate the average peak
fluorescence value and standard error of at least three independent
biological replicates.
2.5. DNA amplification and sequencing
To examine the OMA1 nucleotide sequence encoding the N-terminal
a.a. 122–141, forward primers TCAAGATGCCTCTCAAGTGC and
CATTTCTGTAGGACTCTCAAGAA and reverse primer CTGCCCA
CAATGATAGCAAG were used to amplify 241 and 211 nt, respectively,
of Exon 1 of the OMA1 gene. Reactions included forward and reverse
primer pairs, 1 μg of H9c2 total cellular DNA template, dNTPs, Taq
polymerase (Roche), and DMSO in 80 μLs total volume. Amplifications
were cycled at: 94 ◦ C 1 min, 58 ◦ C 1 min., 72 ◦ C 5 min. for 39 cycles,
followed by 72◦ 10 min. Reactions were checked via 1% agarose gel
electrophoresis in 1X TAE buffer. Successful reactions were purified
using Roche High Pure PCR Product Purification Kit. Three reactions of
each forward/reverse primer pair amplification were sequenced by the
University of Chicago DNA Sequencing and Genotyping Facility.
Sequence data was compared with the NCBI reference sequence for
R. norvegicus OMA1 (NM_001106669.1).
2.6. Gene expression
To analyze gene expression via quantitative reverse transcriptase
PCR (qRT-PCR), H9c2 cells grown on 10 cm dishes were processed for
total RNA using QIAGEN RNeasy kit, and cDNA prepared using Super
script Reverse Transcriptase (Invitrogen, Carlsbad, CA). The following
forward (F) and Reverse (R) primer sets to the indicated R. norvegicus
mRNAs were used: ActB: F: TGTCACCAACTGGGACGATA R:
CTTTTCACGGTTGGCCTTAG, AFG3L2: F: CTGCCTCCGTACGCTTTATC
R: TTCAAATCCTTTGGGAGGTC, Atp2a2: F: TACTGACCCTGTCCCT
GACC R: ACCATTTCATCCCGGATCTT, Bak: F: AAGTTGCCCAGGACA
CAGAG
R:
TGTCCATCTCAGGGTTAGCA,
Bax,
F:
TGCTAGCAAACTGGTGCTCA R: GGTCCCGAAGTAGGAAAGGA, Drp1:
F: ATGGCAACATCAGAGGCACT R: ACTACCCTTCCCAATAAGG, Mybl2:
F: CCACGAGGAGGATGAGCTAC R: CTGGATTCAAAACCCTCAGC,
MyoD: F: CGTGGCAGTGAGCACTACAG R: TGTAGTAGGCGGCGTCG
TAG, MyoG: F: TCCAGTACATTGAGCGCCTA R: GCTGTGGGAGTTG
CATTCAC,
Myom2:
F:
CACAGCGCTTTCATGTTTGT
R:
GGTGGTTTCCAAGTCACGAT, Oma1: F: ATCCTCTAAGCCCTGCTTCC R:
GTAACATCCGTCCCCGTATT, Opa1: F: CATACTAGGATCGGCTGTTGG
R: ACTGTAACACACCCTTTAACT p53: F: CAGTCAGGGACAGCCAAGTC
R:
GTACCAGGTGGAGGTGTGGA,
Ryr1L:
F:
ATACTGTG
GAGGCCGGTGTA
R:
GAGGTGGTGAGGCAACTCAG,
Sln:
F:
CTGGAGTTCTCACCCAGACC R: TGGCCCCTCAGTATTGGTAG, Tnnt2: F:
AGAGGACTCCAAACCCAAGC R: AGTCTGCAGCTCGTTCAGGT, YME1L:
F: GCTTGTACAGGCAACATCCA R: TCTGTGCTTCTGCTAATCTTTCA.
Samples were analyzed via SYBR Green on an Eco Illumina Real-time
system (Illumina, San Diego, CA). Expression levels for each were
normalized to actin (ActB).

2.3. Immunoblotting
For SDS-PAGE Western blotting, cells on 10 cm dishes were lysed in
Laemmli buffer with β-mercaptoethanol (Bio-Rad). Equal volumes of
cell lysates were electrophoresed through 6% (for OPA1), 10% (for
OMA1), or 10–20% (for all others) acrylamide gels and transferred to
Immobilon PVDF (Bio-Rad). For cellular fractionation to obtain cyto
solic and crude mitochondrial fractions, 4–6 10 cm dishes of activelydividing H9c2s were pooled and processed using the Mitochondria
Isolation Kit for Cultured Cells (ThermoFisher 89874), and mitochon
drial pellets resuspended in 1% CHAPS in TBS. Protein concentration of
cytosolic and mitochondrial fractions were measured by A280 using a
NanoDrop spectrophotometer. 10 μg of protein were resuspended in
Laemmli buffer with β -mercaptoethanol, electrophoresed on a 10%
polyacrylamide gel and transferred to PVDF. Membranes were blocked
with 5% nonfat milk in Tris-buffered saline + Tween (TBST). Primary
antibody incubations were: OPA1 (BD Biosci. 612606) 1:500 overnight
at 4 ◦ C, OMA1 (Santa Cruz, H-11 sc-515788), 1:200 overnight at 4 ◦ C,
tubulin (Sigma, T6074) 1:1000 1 h, AFG3L2 (Invitrogen, PA5-48533)
1:1000, Bax (Cell Signaling, 2272) 1:1000 overnight 4 ◦ C, VDAC
(Abcam ab14734) 1 mg/mL, YME1L (Abgent AP4882a) 1:1000. Mem
branes were incubated with secondary goat anti-mouse poly-HRP
(Invitrogen, 32230) or goat anti-rabbit poly-HRP at 1:3000 dilution for 1
h, washed, and developed using WestDura SuperSignal (Thermo,
34076). OMA1 blots required a high salt wash (1 g NaCl in 50 mL TBST)
prior to developing. Blots were visualized using a GelDoc XR + Gel
Documentation System (Bio-Rad). Each blot shown in a figure is repre
sentative of results obtained in at least three independent biological
replicates. Similarly, ImageJ quantitation of immunoblots was per
formed on at least three independent biological replicates in all cases.

2.7. Statistical analyses
Each experiment shown in the figures is representative of results
obtained in at least three independent experiments (biological repli
cates) for reproducibility. For ImageJ analyses of OPA1 isoforms, sam
ples were analyzed via one-tailed Student’s t-test. Data presented are the
averaged mean with standard error. For ImageJ analysis of mitochon
drial circularity, images were analyzed using one-way ANOVA with
Tukey’s HSD. Data presented are the average mean with standard error.
For comparison of mRNA expression in H9c2s grown in standard versus
differentiation media, samples were analyzed via Student’s t-test. In all
experiments and analyses, P < 0.05 was considered to be statistically
significant. *P < 0.05, **P < 0.01, and ***P < 0.001.

2.4. Flow cytometry
To monitor Δψm, TMRE flow cytometry was used as previously
(Jones et al., 2017; Garcia et al., 2018). Cells in 10 cm dishes were
incubated with 100 nM tetramethyl rhodamine ester (TMRE, Invitrogen)
in fresh media for 20 min, washed twice with PBS, and resuspended in 1
90
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3. Results and discussion

was disrupted to a completely fragmented state (Fig. 1A). Similarly,
upon CCCP challenge, mitochondria of 143B cells collapsed to a frag
mented collection of round organelles (Fig. 1A), consistent with previ
ous results (Jones et al., 2017). Blinded ImageJ quantification of
mitochondrial images (Dagda et al., 2009; Garcia et al., 2018) revealed
significant increases in mitochondrial circularity for untreated versus
CCCP-treated H9c2s (0.46 ± 0.02 versus 0.66 ± 0.01) and for control
143Bs (0.45 ± 0.02 versus 0.65 ± 0.02) (Fig. 1B), demonstrating
mitochondrial fragmentation in both cell lines in response to CCCP. Flow
cytometry using tetramethyl rhodamine ester (TMRE) allows moni
toring of Δψm (Jones et al., 2017; Gilkerson et al., 2012): TMRE fluo
rescence was significantly decreased in untreated versus CCCP-treated
cells of both H9c2s (10177 ± 715 versus 4858 ± 268 a.u.) and 143Bs
(4858 ± 268 a.u. versus 385 ± 23 a.u.) (Fig. 1C), demonstrating dissi
pation of Δψm in both H9c2 cardiomyoblast and 143B osteosarcoma cell
lines. These data demonstrate that loss of Δψm via CCCP treatment

3.1. Loss of Δψ m causes mitochondrial fragmentation in H9c2
cardiomyoblasts
CCCP is a protonophore that dissipates Δψm, causing mitochondrial
fragmentation in cultured cells (Legros et al., 2002). Previously, we
showed that a threshold of 34% Δψm, relative to untreated controls, is
required for mitochondrial interconnection in 143B osteosarcoma cells
(Jones et al., 2017). To explore Δψm-sensitive mitochondrial dynamics
in cardiac-derived cells, H9c2 cardiomyoblasts and control 143B cells
were incubated with 10 μM CCCP for 1 h, followed by immunofluores
cence to visualize mitochondrial organization. Untreated H9c2s dis
played mitochondrial organization of both interconnected reticular and
isolated organelles, reflecting a balance of fission and fusion events. In
response to challenge with CCCP, the mitochondrial network of H9c2s

Fig. 2. Δψm-sensitive cleavage of OPA1 is not activated in H9c2 cells. A. H9c2 and 143B cells were challenged with CCCP (10 μM, 1 h) followed by OPA1
immunoblotting. n = 4 experiments (biological replicates). B. ImageJ quantification of L-OPA1 in H9c2s and 143Bs. n = 3 experiments, ± standard error. *** denotes
p < 0.001. C. OPA1 immunoblotting of H9c2 and 143B cell lysates following challenge with CCCP (10 μM, 4 h), n = 3 experiments. D. OMA1 immunoblotting of
143B, H9c2 and OMA1+/+ and − /− cell lysates treated with 10 μM CCCP for 0, 1, or 4 h, n = 4 experiments. E. YME1L immunoblotting of 143B and H9c2 cell
lysates treated with 10 μM CCCP for 0, 1, or 4 h, n = 3 experiments. F. AFG3L2 immunoblotting of 143B and H9c2 cell lysates treated with 10 μM CCCP for 0, 1, or 4
h, n = 3 experiments. G. Representative electropherogram of DNA sequence analysis of OMA1 nt445-473, encoding the N-terminal Δ ψm sensor domain. Identical
results were obtained in sequencing reactions of two independent primer sets, with three amplicons of each sequenced. H. Alignment of reference sequence (ref) NCBI
NM_001106669 and H9c2 sequence at nt445-473, indicating no sequence differences (blue).
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causes loss of mitochondrial interconnection in H9c2 cardiomyoblast
cells, consistent with results in other cellular backgrounds (Legros et al.,
2002). We next examined the status of mitochondrial OPA1 in this
setting.

OMA1 gene, we examined the relevant sequence via PCR of isolated
H9c2 DNA. The a.a.144–163 domain of human OMA1 corresponds to
the rat OMA1 a.a. 122–141, encoded by nt445-473 of the OMA1 coding
sequence. PCR amplification and sequencing of this region (Fig. 2G)
demonstrated that this region in H9c2s is identical to the NCBI reference
sequence (Fig. 2H), indicating that the observed insensitivity of OMA1
to loss of Δψm in H9c2s is not due to mutation or deletion of OMA1′ s
Δψm sensor domain (Baker et al., 2014).
Taken together, these results indicate that L-OPA1 isoforms are
retained in H9c2 cardiomyoblasts despite loss of Δψm, likely through a
failure to activate OMA1. In vivo, OPA1 plays a key role as an apoptotic
switch in cardiac tissue (Wai, 2015). We therefore investigated whether
cardiac-like differentiation of H9c2s would potentiate Δ ψm-sensitive
OPA1 cleavage in this system.

3.2. L-OPA1 is retained in H9c2s following loss of Δψ m, despite the
presence of OMA1
OPA1 is cleaved by the YME1L and OMA1 proteases, creating a
steady-state equilibrium of long, fusion-active L-OPA1 and short, fusioninactive S-OPA1 isoforms (Anand et al., 2014). In response to loss of
Δψm, however, L-OPA1 is typically cleaved to S-OPA1 isoforms (Gri
paric et al., 2007; Baricault et al., 2007). OPA1 immunoblotting showed
that untreated H9c2s maintain steady-state L-OPA1 and S-OPA1 levels.
Strikingly, however, under CCCP challenge (10 μM, 1 h), untreated and
CCCP-treated H9c2s maintained equivalent proportions of L-OPA1
(Fig. 2A). Conversely, untreated 143B cells maintained a balance of LOPA1 and S-OPA1, while CCCP induced the expected loss of L-OPA1 and
concomitant accumulation of S-OPA1 (Fig. 2A), as shown previously
(Jones et al., 2017). ImageJ quantification confirmed that in H9c2s there
was no difference in L-OPA1 levels in untreated (59.2 ± 4%) versus
CCCP-treated cells (58.9 ± 2%) (Fig. 2B), while untreated 143B cells had
significantly greater L-OPA1 than CCCP-treated cells (52.5 ± 4% versus
16.5 ± 0.6%). The CCCP-induced mitochondrial fragmentation in Fig. 1
is surprising in light of the presence of L-OPA1 in H9c2s under CCCP
challenge. Notably, OPA1-mediated mitochondrial fusion is opposed by
mitochondrial fission, mediated by recruitment of dynamin-related
protein-1 (DRP1) to the organelle, where it carries out membrane scis
sion. Mitochondrial recruitment of DRP1 is carried out by the actin
cytoskeleton (Ji et al., 2015; Hatch et al., 2014; Moore, 2016) in
response to stimuli including AMP kinase (Toyama et al., 2016) and
uncouplers (Cereghetti et al., 2008), suggesting that the observed CCCPinduced mitochondrial fragmentation is mediated by DRP1. Moreover,
longer incubation with CCCP (four hours) also failed to elicit any
appreciable L-OPA1 cleavage (Fig. 2C). These data demonstrate that LOPA1 is retained under loss of Δ ψm in H9c2s, representing a novel
departure from Δ ψm-sensitive OPA1 dynamics reported in other cell
settings (Griparic et al., 2007; Ishihara et al., 2006; Ehses et al., 2009;
Rainbolt et al., 2016).
As Δψm-sensitive cleavage of L-OPA1 is carried out by OMA1 (Head
et al., 2009; Ehses et al., 2009), we next tested whether OMA1 was
present in H9c2s. OMA1 immunoblotting of lysates from untreated 143B
and H9c2 cells both displayed signal for OMA1, which was missing from
control OMA1− /− cells (Fig. 2D), demonstrating that the lack of OPA1
cleavage in CCCP-treated H9c2s was not due to the absence of OMA1. In
response to loss of Δψm, OMA1 activates proteolysis of L-OPA1, followed
by degradation of OMA1 (Rainbolt et al., 2016; Zhang et al., 2014).
While OMA1 was present in untreated 143B cells, 143Bs showed loss of
OMA1 signal after 4 h of CCCP treatment, relative to loading controls.
Conversely, H9c2s showed no reduction in OMA1 in response to CCCP
challenge at 1 or 4 h. (Fig. 2D), indicating that OMA1 activation and
degradation did not occur. OMA1 degradation following loss of Δψm
requires YME1L (Rainbolt et al., 2016), but YME1L is present in both
H9c2s and 143Bs without and with CCCP challenge (Fig. 2E). Similarly,
the matrix-localized AFG3L2 protease cooperates with YME1L to regu
late OMA1 activity (Consolato et al., 2018). AFG3L2 immunoblotting
revealed that both H9c2 and 143B cells displayed AFG3L2 signal,
though H9c2s displayed less, relative to loading controls (Fig. 2F). Thus,
OMA1, and its partners YME1L and AFG3L2, are expressed in H9c2s, but
OMA1 is apparently neither activated nor degraded in response to loss of
Δψm.
Langer and co-workers found that a conserved N-terminal domain of
OMA1 (a.a. 144–163) is required for its activation and cleavage of LOPA1 following dissipation of Δψm (Baker et al., 2014). To test whether
the lack of L-OPA1 cleavage under CCCP challenge in H9c2s (Fig. 2A)
might be due to a mutation in the corresponding domain of the rat

3.3. Retinoic acid-mediated differentiation activates L-OPA1 cleavage in
H9c2s
H9c2 cells can be induced to differentiate towards skeletal or cardiac
muscle phenotypes: when grown in low-serum media, H9c2 cells form
myotubes and express skeletal muscle markers, while growth in lowserum media containing RA promotes expression of cardiac markers
for a cardiomyocyte-like phenotype (Branco et al., 2015, 2011). To
explore the impact of cardiac differentiation on Δψm-sensitive L-OPA1
cleavage, H9c2s were grown in differentiation media containing 1% FBS
with 1 μM RA for 5 days (Branco et al., 2015). When visualized by
confocal microscopy, H9c2s grown in standard media (DMEM contain
ing 10% FBS) showed blast-type morphology consistent with activelydividing cultured cells. When grown in media containing 1% FBS +
RA, however, H9c2s transitioned to an elongate cellular morphology,
with frequent binucleate cells (Fig. 3A), consistent with differentiation
to a more cardiac-like state (Branco et al., 2015). To examine cardiacspecific differentiation, mRNAs were examined by quantitative reverse
transcription PCR (qRT-PCR). Strikingly, significant increases in the
expression of cardiac-specific genes were observed in differentiated
H9c2s: cardiac troponin T (Tnnt2, 24-fold), myomesin 2 (Myom2, 7fold), myogenin (Myog, 3.5-fold), ryanodine receptor 1 (Ryr1l, 4-fold),
sarcolipin (Sln, 7-fold), and the sarcoplasmic calcium transporter
ATP2a1 (5-fold) all showed significantly increased mRNA expression.
Conversely, the Mybl2 cell cycle progression factor showed decreased
expression, while expression of Myod, which promotes skeletal (not
cardiac) muscle differentiation, was not increased (Fig. 3B). Taken
together, these data indicate that H9c2s differentiate upon treatment
with low serum plus RA, exiting the cell cycle and committing to a
cardiac-specific state. We next examined the effect of RA-mediated dif
ferentiation on Δψm-sensitive OPA1 cleavage in H9c2s.
Following incubation in differentiation media, control and differ
entiated H9c2s were challenged with CCCP. Undifferentiated H9c2s
maintained an average TMRE value of 5881 ± 568 a.u., falling to 1367
± 542 in response to CCCP for a significant decrease in Δψm. Differen
tiated H9c2s had a TMRE value of 6865 ± 292, decreasing to 1998 ± 378
following CCCP treatment (Fig. 3C). Thus, the loss of TMRE in response
to CCCP was equivalent in undifferentiated versus RA-differentiated
H9c2s. OPA1 immunoblotting revealed that untreated H9c2s had a
balance of both L-OPA1 and S-OPA1 isoforms, maintaining L-OPA1
under CCCP challenge, as in Fig. 2. RA-treated H9c2s similarly main
tained both L-OPA1 and S-OPA1 isoforms. Strikingly, however, RAtreated H9c2s showed a dramatic loss of L-OPA1 in response to CCCP
treatment (Fig. 3D). ImageJ quantification confirmed that while undif
ferentiated H9c2s showed no difference in L-OPA1 levels (61 ± 4%
control versus 56 ± 4% CCCP-treated), RA-differentiated H9c2s showed
a robust, significant loss of L-OPA1 in response to CCCP challenge (57 ±
3% control versus 16 ± 5% CCCP-treated) (Fig. 3E). Consistent with this,
RA-treated H9c2s maintain interconnected mitochondria, collapsing to
a fragmented morphology upon CCCP treatment (Fig. 3F). These results
demonstrate that Δψm-sensitive L-OPA1 cleavage is vigorously activated
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Fig. 3. RA-mediated differentiation acti
vates Δψm-sensitive OPA1 cleavage in
H9c2s. A. Confocal imaging of H9c2s grown
in standard (DMEM + 10% FBS) or differ
entiation media (DMEM + 1% FBS + 1 μM
RA) for five days. Actin (phalloidin, green),
and nuclei (DAPI, blue) were visualized by
confocal microscopy. B. Gene expression of
differentiation markers in H9c2s in standard
(white) or differentiation (black) media.
qRT-PCR for indicated mRNAs, ± standard
error. ** denotes p < 0.01. C. TMRE flow
cytometry analysis for Δ ψm in standard or
differentiation media without or with 10 μM
CCCP, 1 h. n = 3 experiments. D. H9c2s
grown in standard or differentiation media
were challenged with CCCP for 1 h followed
by immunoblotting for OPA1. E. ImageJ
quantification of OPA1 immunoblots. n = 4
experiments, ± standard error. *** denotes p
< 0.01. F. Mitochondrial morphology of
H9c2s differentiated with 1% FBS + 1 μM
RA. Cells were incubated with MitoTracker,
followed by CCCP challenge and fixation.
Mitochondria (MitoTracker, red) and nuclei
(DAPI, blue) were visualized by confocal
microscopy. n = 3 expts. G. OMA1 and
tubulin immunoblotting of H9c2s grown in
standard or differentiation media challenged
with 10 μM CCCP for 0, 1, or 4 h, n = 4 ex
periments. (For interpretation of the refer
ences to colour in this figure legend, the
reader is referred to the web version of this
article.)

in RA-differentiated H9c2 cells. As loss of Δψm activates OMA1 cleavage
of L-OPA1, followed by subsequent YME1L-dependent degradation of
OMA1 (Rainbolt et al., 2016; Zhang et al., 2014), we next examined
whether RA differentiation restored degradation of OMA1 following
CCCP challenge. In undifferentiated H9c2s, OMA1 was not degraded
following CCCP challenge of 1 or 4 h. In RA-differentiated H9c2s,
however, CCCP induced loss of OMA1 after 4 h. (Fig. 3G), consistent
with CCCP-induced activation and subsequent degradation of OMA1 in
RA-differentiated H9c2s. Together, these results demonstrate that RAmediated differentiation robustly activates CCCP-induced L-OPA1
cleavage, and indicate that Δψm-sensitive OPA1 cleavage is regulated by
a developmental switch in H9c2 cells.

examined the mRNA expression of factors involved in mitochondrial
dynamics and candidate interacting factors. While RA differentiation
did not alter the expression of OPA1, OMA1, DRP1, YME1L, or p53, RA
differentiation caused significant increases in the expression of AFG3L2
(2-fold) and pro-apoptotic factors Bax (1.8-fold) and Bak (1.5-fold)
(Fig. 4A). As an inhibitor of mitochondrial protein synthesis (Storrie and
Attardi, 1973; Hilander et al., 2018), chloramphenicol (CAP) prevents
stress-induced OPA1 cleavage in cells with decreased AFG3L2 (Mancini
et al., 2019; Richter et al., 2019). To examine whether RA-induced OPA1
cleavage is sensitive to CAP, H9c2s were differentiated for five days, as
above, in the absence or presence of CAP for the final three days
(Hilander et al., 2018), followed by CCCP treatment. RA-differentiated
H9c2s maintain L-OPA1, which is strongly cleaved following CCCP
challenge, as above. RA-differentiated H9c2s treated with CAP prior to
challenge with CCCP also show complete cleavage of L-OPA1 (Fig. 4B),
demonstrating that RA-induced OPA1 cleavage is not CAP-sensitive and
indicating that the observed switch is not dependent on mitochondrial

3.4. RA-mediated OPA1 cleavage is reversible and chloramphenicolinsensitive
To explore potential mechanisms of this intriguing switch, we
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Fig. 4. RA-mediated activation of Δψm-sensitive OPA1 cleavage is reversible, but chloramphenicol-insensitive. A. qRT-PCR of indicated mRNAs from H9c2s grown in
standard (10% FBS, white) or differentiation (1% FBS + RA, black) media, ± standard error. ** denotes p < 0.01. B. OPA1 immunoblotting of RA-differentiated
H9c2s treated with CAP (40 μg/mL, 3 d) and challenged with CCCP (10 μM, 1 h). n = 3 experiments. C. Immunoblotting of cytosolic (c) and mitochondrial (m)
fractions (10 μg per lane) from H9c2s in regular (10% FBS) and differentiation (1% FBS + RA) media, without or with CCCP. n = 3 experiments. D. OPA1 and tubulin
immunoblotting of H9c2s grown in glucose (+glu) or galactose (-glu + gal) media and challenged with CCCP (10 μM, 1 h). n = 3 experiments. E. OPA1 and tubulin
immunoblotting of cell lysates from 10% FBS, 1% FBS + RA, and RA + recov. H9c2s were differentiated in 1% FBS + RA for 5 d and then allowed to recover for 5 d in
10% FBS (RA + recov.). n = 3 experiments. F. ImageJ quantification of OPA1 immunoblots in E. n = 3 experiments, ± standard error. * denotes p < 0.05, **denotes
p < 0.01, ***denotes p < 0.001.

protein synthesis.
Given the increased expression of pro-apoptotic Bax and Bak in RAtreated H9c2s, we next examined whether Bax is involved in RA-induced
OPA1 cleavage. Bax is a cytosolic factor that is translocated to mito
chondria in response to a variety of stimuli, where it promotes cyto
chrome c release and subsequent caspase-mediated apoptosis (Eskes
et al., 2000; Wolter et al., 1997). Bax and Bak oligomerize within the
mitochondria to activate OMA1 (Jiang et al., 2014). To test whether
increased mitochondrial translocation of Bax correlates with RAinduced OPA1 cleavage, cytosolic and mitochondrial fractions of con
trol and RA-differentiated H9c2s (without or with CCCP) were prepared.
In undifferentiated H9c2s, Bax was predominantly found in the cytosolic
fraction, coincident with tubulin. Faint Bax bands were found in

mitochondrial fractions, coincident with mitochondrial voltagedependent anion channel (VDAC) (Fig. 4C). Similarly, RAdifferentiated H9c2s showed strong Bax signal in the cytosolic frac
tions of control and CCCP-treated cells, with faint bands in the mito
chondrial fractions (Fig. 4C). As such, RA differentiation does not appear
to cause an appreciable increase in mitochondrial translocation of Bax in
response to CCCP.
OPA1 processing is modulated in RPE1 cells by changing from high
glucose media to glucose-free media supplemented with galactose
(MacVicar and Lane, 2014), thus switching from glycolytic to oxidative
metabolism (Rossignol et al., 2004). To test whether OPA1 processing in
H9c2s is impacted by metabolic shifting, H9c2s were incubated in
DMEM lacking glucose supplemented with galactose, followed by CCCP
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challenge. H9c2s grown in high glucose maintain L-OPA1 isoforms,
either without or with CCCP challenge (Fig. 4D), as in Fig. 2. Similarly,
H9c2s grown in media lacking glucose, supplemented with galactose,
retain L-OPA1, even under CCCP challenge (Fig. 4D), indicating that
shifting metabolism does not activate OPA1 processing in H9c2s.
Consistent with this, RA-mediated differentiation of H9c2s does not
significantly alter steady-state Δ ψm of H9c2s (Fig. 3C). Moreover, RAmediated differentiation is carried out in high glucose media. Taken
together, these results suggest that the observed induction of Δ ψmsensitive OPA1 processing in RA-treated H9c2s is not mediated by
increased mitochondrial metabolism. We next tested whether RA in
duction of Δ ψm-sensitive L-OPA1 cleavage is reversible. H9c2s were
differentiated for 5 days in RA, followed by recovery in media with 10%
FBS lacking RA for an additional 5 days. While untreated H9c2s showed
no L-OPA1 cleavage in response to CCCP, RA-differentiated H9c2s dis
played robust cleavage of L-OPA1 in response to CCCP challenge (as in
Fig. 3D). Differentiated H9c2s allowed to recover in DMEM with 10%
FBS, however, retain L-OPA1 when challenged with CCCP (Fig. 4E).
ImageJ quantification confirms that while H9c2s that recover in stan
dard media do show some reduction in L-OPA1 under CCCP challenge,
they retain significantly more L-OPA1 than RA-differentiated H9c2s
given CCCP (Fig. 4F). These results demonstrate that the induction of
Δψm-sensitive L-OPA1 cleavage in differentiated H9c2s is reversible
upon removal of RA and restoration of serum.
The robust switching of Δψm-sensitive L-OPA1 cleavage suggests that
RA differentiation activates a potent regulatory mechanism for OMA1,
opening new avenues of inquiry regarding the mechanistic regulation of
Δψm-sensitive OPA1 cleavage, as well as a novel developmental role for
this stress-sensing mechanism. Mechanistically, the stress-sensitive
activation of OMA1 remains unclear. Our findings add a provocative
new element to this question, suggesting that an unknown,
developmentally-regulated molecular ‘clutch’ is able to engage, and
disengage, this key mechanism of mitochondrial stress response. OMA1
interacts with YME1L (Song et al., 2007; Anand et al., 2014; Rainbolt
et al., 2016), AFG3L2 (Consolato et al., 2018), and cardiolipin (allowing
indirect association with prohibitin (Anderson et al., 2020), suggesting
that improved understanding of OMA1′ s homo-oligomeric structure
(Bohovych et al., 2014), interacting partners, and the inner membrane
proteolipid environment will be crucial to fully delineating the mecha
nisms behind stress-sensitive cleavage of OPA1. Developmental regula
tion of L-OPA1 cleavage has not been demonstrated previously, despite
emerging evidence indicating potent roles for OPA1 in differentiation:
ablation of OPA1 disrupts neural (Caglayan et al., 2020) and cardiac
development (Kasahara et al., 2013), as well as stem cell maintenance
(Sênos Demarco et al., 2019). A developmental switch activating stresssensitive OPA1 cleavage in differentiated cardiac cells is consistent with
OPA1′ s established role in priming cells for apoptosis (Head et al., 2009;
Jiang et al., 2014) and induction of pro-apoptotic factors in RAdifferentiated H9c2s (Fig. 4A; y (Branco et al., 2015). These findings
hold exciting potential for other cell settings, including stem, neuronal,
and additional cardiac cell systems, in exploring the generality of this
intriguing switch.
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